Bo Jiao
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 4
- Pharmaceutical Science top 5%
-
- Protein Kinase Regulation and GTPase Signaling 5
- Epigenetics and DNA Methylation 4
-
- Pneumonia and Respiratory Infections 6
-
- Antibiotic Resistance in Bacteria 4
-
- Acute Lymphoblastic Leukemia research 4
-
- Cardiac Ischemia and Reperfusion 4
- Co-authors
- Ruibao RenYaoqiu ZhuJiang ZhouPing LiuYiping WangLeilei ChenYanping XuPu Wang
- Journals
- BioScience Trends (3 papers)Chinese Chemical Letters (3 papers)Frontiers of Medicine (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Bo Jiao
54 papers receiving 869 citations
Peers
Comparison fields: 5 of 109
- Hematology 221
- Pharmaceutical Science 61
- Molecular Biology 495
- Cancer Research 94
- Genetics 50
Countries citing papers authored by Bo Jiao
This map shows the geographic impact of Bo Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Jiao more than expected).
Fields of papers citing papers by Bo Jiao
This network shows the impact of papers produced by Bo Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Jiao. The network helps show where Bo Jiao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Jiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 22 | |
| 10 | 2020 | 15 | |
| 11 | 2016 | 14 | |
| 12 | 2015 | 20 | |
| 13 | 2015 | 224 | |
| 14 | 2014 | 9 | |
| 15 | 2013 | 12 | |
| 16 | 2012 | 48 | |
| 17 | 2010 | 11 | |
| 18 | 2010 | 13 | |
| 19 | 2010 | 7 | |
| 20 | 2009 | 16 |
About Bo Jiao
Bo Jiao is a scholar working on Hematology, Molecular Medicine and Nephrology, having authored 56 papers that have together received 882 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers), Epigenetics and DNA Methylation (4 papers), Antibiotic Resistance in Bacteria (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). The work is most often cited by research in Hematology (221 citations), Pharmaceutical Science (61 citations) and Molecular Biology (495 citations). Bo Jiao has collaborated with scholars based in China, United States and France. Frequent co-authors include Ruibao Ren, Yaoqiu Zhu, Jiang Zhou, Ping Liu, Yiping Wang, Leilei Chen, Yanping Xu, Pu Wang, Hui Yang and Huaipeng Lin. Their work appears in journals such as BioScience Trends, Chinese Chemical Letters, Frontiers of Medicine, Blood and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.